j.erdogan
TL2 · Kolkata
Contributes reviews on supplier material. Based in Kolkata.
Joined 5 August 2025 · last posted 7d
71 posts, newest first. Showing up to 150.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #78 · Analytics › Home & field testing · 21 Jul 2026 · 2 likes Everything in post #76 holds. The case it does not cover is the one I have. The right question for any home test is: what physical quantity does it measure, and what…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #61 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 24 likes Post #60 and I disagree about the size of the effect, not about the direction. Before anything else: what was the gradient, and at what wavelength? Area percent at…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #6 · Clinical › Bloodwork · 16 Jul 2026 · 0 likes One caution on egfr fluctuation: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
How much context is too much context in a first post? Replied, post #69 · Start Here › How to Ask · 10 Jul 2026 · 8 likes On post #66 — agreed on the reasoning, with one qualification. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #141 · Practice › Interactions · 6 Jul 2026 · 27 likes I would keep Metformin co-administration and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #62 · Analytics › Impurities & related substances · 30 Jun 2026 · 0 likes Two sentences on Endotoxin and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
Asking a follow-up: new topic or new reply? Replied, post #27 · Start Here › How to Ask · 27 Jun 2026 · 1 like It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #50 · Evidence › Journal club · 25 Jun 2026 · 0 likes The confident answers on STEP 1 and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Revisiting: The best-written scientific paper you have read Replied, post #41 · Lounge › Off topic · 20 Jun 2026 · 32 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
-
Prescription requirements and telehealth models — a second dataset Replied, post #67 · Sourcing › Regulatory · 16 Jun 2026 · 17 likes Prescription requirements and telehealth models is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #26 · Pharmacology › Pharmacokinetics · 16 Jun 2026 · 20 likes Narrowing post #25, because the general version has more than one answer. Washout after stopping takes roughly the same four to five half-lives as reaching steady…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #71 · Devices › Syringes & needles · 13 Jun 2026 · 3 likes A definition problem is doing most of the work in this 0.3 ml versus 0.5 ml discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #100 · Practice › Storage & stability · 8 Jun 2026 · 5 likes The arithmetic in post #97 is right; the assumption feeding it is the part to check. Reporting rather than recommending, on reconstituted. What happened is above.…
-
Forced degradation studies: designing one that is informative Replied, post #72 · Analytics › Method validation · 8 Jun 2026 · 4 likes Building on post #70 rather than restating it. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #4 · Research Methods › N-of-1 designs · 7 Jun 2026 · 4 likes Reporting rather than recommending, on Blinding yourself. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #62 · Sourcing › Red flags · 5 Jun 2026 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Shakes versus food: a pragmatic assessment Replied, post #14 · Nutrition & Training › Protein & intake · 4 Jun 2026 · 0 likes Post #12 put the caveat in the right place and I want to underline it. Shakes versus food is worth one more sentence than it usually gets, and the sentence is the one…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #20 · Sourcing › Payments · 28 May 2026 · 2 likes Currency conversion is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Reading a trial's population section before its results Replied, post #51 · Evidence › Trials · 25 May 2026 · 4 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Revisiting: Mobile reading experience on long topics Replied, post #5 · Meta › Site feedback · 6 May 2026 · 18 likes Fair, and the limits you put on it are the part I will remember.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #42 · Clinical › Comorbidities · 5 May 2026 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #26 · Practice › Reconstitution · 26 Apr 2026 · 0 likes The arithmetic in post #25 is right; the assumption feeding it is the part to check. How much of the diluent volume the powder itself displaces: for a small peptide…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #118 · Practice › Reconstitution · 25 Apr 2026 · 2 likes Thank you for the correction. I would rather find out here than later.
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #13 · Data & Tools › Calculators · 2 Apr 2026 · 4 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #22 · Evidence › Journal club · 23 Mar 2026 · 16 likes Taking post #21 at face value and following it one step further. I think the orforglipron phase 2 question is answerable and has not been answered, which is a more…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #45 · Practice › Reconstitution · 17 Mar 2026 · 5 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
A promotion I argued against, and why I lost — a second dataset Replied, post #2 · Documentation › Doc review · 11 Mar 2026 · 11 likes Thank you for the correction. I would rather find out here than later.
-
Angle of injection and whether 90 degrees is always right Replied, post #89 · Practice › Administration · 26 Jan 2026 · 2 likes Nothing in this subcategory is medical advice and none of it is a substitute for a demonstration from somebody qualified to give one, which most prescribers will do…
-
What to include when your question involves a chromatogram Replied, post #32 · Start Here › How to Ask · 10 Jan 2026 · 0 likes Post #30 put the caveat in the right place and I want to underline it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
The headache that turns out to be dehydration Replied, post #117 · Nutrition & Training › Hydration & electrolytes · 31 Dec 2025 · 12 likes I read post #113 twice before replying, because I had assumed the opposite. Adding salt to food is the intervention most consistently reported as helping and is also…
-
DXA precision and the least significant change for lean mass Replied, post #68 · Outcomes › Body composition · 14 Dec 2025 · 5 likes Speaking only to DXA precision as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Reading SURMOUNT-1 without the press release Replied, post #91 · Compounds › Tirzepatide · 6 Dec 2025 · 18 likes Post #90 describes the usual case. This is about the unusual one. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea…
-
Reading SURMOUNT-1 without the press release Replied, post #74 · Compounds › Tirzepatide · 22 Nov 2025 · 31 likes Two questions I would want answered before drawing anything from the reading SURMOUNT-1 without the press data above: how were the cases selected, and what happened to…
-
Availability by country, dated, with primary sources Replied, post #57 · Access › International · 12 Nov 2025 · 1 like I read post #56 twice before replying, because I had assumed the opposite. I would call the community position on availability likely rather than established, and I…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #50 · Analytics › Home & field testing · 10 Nov 2025 · 0 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
When to stop reading forums, including this one Replied, post #42 · Wellbeing › Mental health · 28 Oct 2025 · 0 likes Narrowing post #39, because the general version has more than one answer. The social side of this — how other people respond to visible change — comes up constantly and…
-
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #3 · Practice › Administration · 28 Oct 2025 · 31 likes What would change my mind on genuinely late dose is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
-
Substitution between formats during a shortage Replied, post #78 · Access › Shortages · 19 Oct 2025 · 0 likes A shortage of one presentation is not a shortage of all of them, and the published notices are specific about which. If the premise is wrong, everything after it is…
-
Where to report an adverse event officially, by region — a second dataset Started this topic · Safety › Adverse events · 5 Oct 2025 · 16 likes On the subject in the title: Where to report an adverse event officially, by region — a second dataset Working notes rather than a conclusion. Reporting an event with…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 0 likes Answering the question post #63 raises rather than the one it answers. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #59 · Data & Tools › Datasets · 8 Sep 2025 · 18 likes Picking up post #56: that is the part I would want checked first. A codebook describing each field takes twenty minutes and is what makes the file usable by anyone but…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #9 · Practice › Interactions · 28 Aug 2025 · 13 likes Post #8 answers the question as asked. The question underneath it is different. Nobody has said the unglamorous part of Warfarin and altered intake yet, so: most of the…
-
Asking about a compound your prescriber has not heard of Replied, post #120 · Clinical › Prescriber conversations · 9 Aug 2025 · 11 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. That is all the detail I have.…
-
Comparing my trajectory with the trial curves, carefully Replied, post #32 · Outcomes › Progress reports · 5 Aug 2025 · 20 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not. Written from notes rather than memory, which…
-
How to research a compound with no human data without deceiving yourself Replied, post #51 · Compounds › Other compounds · 1 Aug 2025 · 1 like Post #47 put the caveat in the right place and I want to underline it. The honest summary for most of this subcategory: a plausible mechanism, animal data, and…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #27 · Compounds › Secretagogues & GH axis · 1 Aug 2025 · 4 likes Where I part company with post #23, and it is a narrow parting. Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably…
-
When a preprint is the best available evidence and we say so Replied, post #5 · Evidence › Preprints · 28 Jul 2025 · 1 like Adding a data point of agreement rather than a data point.
-
Are there stupid questions here? A staff answer, at length Replied, post #14 · Start Here › Welcome · 26 Jul 2025 · 13 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #63 · Compounds › Semaglutide · 10 Jul 2025 · 4 likes Worth separating two things that post #61 runs together. Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean…
-
Triple agonism: additive, synergistic, or neither? Replied, post #63 · Compounds › Retatrutide · 2 Jul 2025 · 7 likes Triple agonism: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Repeatability versus intermediate precision Replied, post #114 · Analytics › Method validation · 1 Jul 2025 · 7 likes Post #111 is right about the mechanism and I think understates the practical bit. An independent laboratory's method being different from the supplier's is not a…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #71 · Compounds › Retatrutide · 17 Jun 2025 · 23 likes Post #70 answers the question as asked. The question underneath it is different. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison…
-
Research-use-only labelling: what it means and what it does not Replied, post #3 · Sourcing › Regulatory · 12 Jun 2025 · 14 likes That is a fair summary of where the discussion has got to.
-
Coming back to: Official shortage notices and what they authorise Replied, post #18 · Access › Shortages · 31 May 2025 · 0 likes No notes. Posting so the count is not one.
-
Pre-registering a personal experiment, seriously Replied, post #54 · Research Methods › N-of-1 designs · 30 May 2025 · 6 likes Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap.
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #16 · Devices › Syringes & needles · 30 Apr 2025 · 4 likes Answering the question post #14 raises rather than the one it answers. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
Coming back to: Cross-border purchase rules within the EU Started this topic · Regional › European Union · 22 Mar 2025 · 54 likes Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. Cross-border purchase rules within — I have…
-
Criticising the method without criticising the authors Replied, post #38 · Evidence › Study critique · 9 Feb 2025 · 0 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Protein density versus volume when you cannot eat much Replied, post #13 · Nutrition & Training › Protein & intake · 24 Jan 2025 · 11 likes I read post #11 twice before replying, because I had assumed the opposite. What tends to work is front-loading the day, prioritising density over volume, and treating…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #93 · Compounds › Tirzepatide · 31 Dec 2024 · 0 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
Building a sensible monitoring schedule with your prescriber Replied, post #76 · Clinical › Bloodwork · 21 Dec 2024 · 0 likes Building a sensible monitoring schedule is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #27 · Evidence › Journal club · 13 Dec 2024 · 11 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Body image changing more slowly than the body Replied, post #18 · Wellbeing › Mental health · 12 Dec 2024 · 17 likes Post #15 and I disagree about the size of the effect, not about the direction. Identity and self-image: for some people, weight and body size are central to identity.…
-
Gallbladder disease risk with rapid weight loss Replied, post #35 · Clinical › Comorbidities · 24 Nov 2024 · 16 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
-
EMA product information as a primary source — does this still hold? Replied, post #19 · Regional › European Union · 15 Nov 2024 · 2 likes Picking up post #16: that is the part I would want checked first. EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #2 · Compounds › Repair & healing peptides · 10 Nov 2024 · 0 likes Route arguments — local versus systemic — are made confidently in this subcategory on very little published basis. The honest position is that the comparison has not…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #40 · Clinical › Prescriber conversations · 7 Nov 2024 · 6 likes That is a fair summary of where the discussion has got to.
-
Time to steady state after a dose increase Replied, post #153 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 20 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none. Two sources, same…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Started this topic · Compounds › Tirzepatide · 16 Oct 2024 · 15 likes Tirzepatide's shorter half-life and its one practical consequence Writing it up because I had to work it out twice and would rather nobody else did. Documentation…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #2 · Compounds › Semaglutide · 8 Aug 2024 · 9 likes The thing about c-cell question that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #3 · Practice › Dosing & titration · 19 May 2024 · 4 likes Two things can be true about four-week escalation interval at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…